☆ 4.6 Review

A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients

VIRUSES-BASEL (2022)

Related references

Note: Only part of the references are listed.

Article Medical Laboratory Technology

Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response

Ashley Di Meo et al.

Summary: The antibody response to SARS-CoV-2 mRNA vaccines differs significantly between healthcare workers and solid organ transplant recipients. The absolute values generated from each of the assay platforms are not interchangeable, and antibody levels differ with increased time intervals between vaccine administration and blood draw as well as between the first and second dose administration.

JOURNAL OF APPLIED LABORATORY MEDICINE (2022)

Add to Collection

Review Gastroenterology & Hepatology

Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis

Atsushi Sakuraba et al.

Summary: The meta-analysis showed that patients with immune-mediated inflammatory diseases have a reduced response to mRNA COVID-19 vaccines, especially those receiving anti-CD20 and anti-tumor necrosis factor therapy. These patients are less likely to achieve a serologic response even after completing the full vaccine series.

GASTROENTEROLOGY (2022)

Add to Collection

Review Oncology

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

Atsushi Sakuraba et al.

Summary: Patients with cancer, especially those with hematologic B-cell malignancies, have a lower serologic response to COVID-19 vaccines. Additional strategies for prophylaxis should be considered for cancer patients.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Review Infectious Diseases

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis

Alexandre R. Marra et al.

Summary: This study assessed the short-term effectiveness of COVID-19 vaccines among immunocompromised patients and found that they were effective against symptomatic COVID-19 infection but had lower effectiveness compared to the control group. Further research is needed to understand the discordance between antibody production and protection against symptomatic COVID-19 infection.

JOURNAL OF INFECTION (2022)

Add to Collection

Letter Surgery

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

Arnaud Del Bello et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience

Yael Peled et al.

Summary: This study investigated the safety and immunogenicity of a third dose of the Pfizer BNT162b2 vaccine in heart transplant patients. The results showed that the third dose had a low rate of adverse events and elicited a strong immune response.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Add to Collection

Article Immunology

Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the Net State of Immunosuppression

Matthew B. Roberts et al.

Summary: Successful solid organ transplantation requires meticulous attention to immunosuppression details, balancing rejection and infection risks. The state of immune suppression serves as a conceptual framework for infectious risk, with a lack of assays measuring immune function. Adjusting immunosuppression during infections is rarely studied, leading to management largely based on clinical experience.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management

Nicole A. Pilch et al.

Summary: The evolution of immunosuppression regimens in solid organ transplants in the United States over the past 70 years has been marked by significant advancements but also ongoing challenges in achieving the optimal balance between under- and overimmunosuppression. The development of effective regimens has been limited by factors such as the limited number of agents, early stages of HLA matching techniques, and lack of understanding of immunoreactivity. Future directions in transplant immunosuppression aim to move towards patient-specific optimization for optimal long-term outcomes.

PHARMACOTHERAPY (2021)

Add to Collection

Article Urology & Nephrology

B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients

Eva Schrezenmeier et al.

Summary: The study found that 36% of kidney transplant recipients showed seroconversion after receiving a third dose of vaccine, highlighting the need for individual humoral monitoring and continued efforts to adapt vaccination protocols for immunosuppressed individuals. The quantitative and qualitative changes in cellular immunity associated with seroconversion emphasize the importance of modified vaccination approaches for this at-risk group.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Urology & Nephrology

Long-Term Immunosuppression Management Opportunities and Uncertainties

David Wojciechowski et al.

Summary: The long-term management of maintenance immunosuppression in kidney transplant recipients is complex, with various drug regimens having their own advantages and disadvantages. Balancing between treatment efficacy and adverse effects is crucial in decision-making for these patients.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Filippo Massa et al.

Summary: A three-dose regimen of the BNT162b2 COVID-19 vaccine significantly improves anti-spike IgG levels, neutralizing antibodies, and cellular immune responses in kidney transplant recipients with a tolerable tolerability profile.

EBIOMEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Health Care Sciences & Services

Using preprints in evidence synthesis: Commentary on experience during the COVID-19 pandemic

Barbara Clyne et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

Sonsoles Salto-Alejandre et al.

Summary: This study analyzed the characteristics and predictors of unfavorable outcomes in solid organ transplant recipients (SOTRs) with COVID-19. Factors like advanced age, high respiratory rate, lymphopenia, and elevated level of lactate dehydrogenase were identified as independent predictors of ICU admission or death. Early diagnosis of COVID-19 post-transplantation was associated with poorer clinical prognosis.

PLOS ONE (2021)

Add to Collection

Article Surgery

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

Nathalie Chavarot et al.

Summary: Poor responses to mRNA COVID-19 vaccine were observed in kidney transplant recipients treated with belatacept, especially in those without prior COVID-19 history. However, patients with a history of COVID-19 developed a strong antibody response with high titers after vaccination. Further strategies are needed to improve protection in this population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Tackling COVID-19 with neutralizing monoclonal antibodies

Davide Corti et al.

Summary: Monoclonal antibodies have revolutionized the treatment of several human diseases, including cancer, autoimmunity, and infectious diseases. Lessons learned from the COVID-19 pandemic have paved the way for the development of more monoclonal antibody-based therapeutics.

CELL (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Urology & Nephrology

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response

Christophe Masset et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse

Timm H. Westhoff et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Medicine, General & Internal

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

Madhumita Shrotri et al.

LANCET (2021)

Add to Collection

News Item Multidisciplinary Sciences

SIX MONTHS, 1.7 BILLION DOSES: WHAT WE'VE LEARNT ABOUT COVID VACCINES

Heidi Ledford

Summary: Nature explores important questions about vaccines being rushed out by countries as viral variants continue to spread globally at a crucial moment in the pandemic.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk et al.

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment

Nizam Mamode et al.

Summary: This study compared outcomes of kidney transplant recipients and patients on the waiting list admitted to hospital with COVID-19 in a high-prevalence region, finding similar mortality rates between the two groups but higher mortality in older transplant recipients. These findings should guide decisions on transplantation during the COVID era.

TRANSPLANTATION (2021)

Add to Collection

Article Nutrition & Dietetics

Coronavirus Disease 2019 (COVID-19) Meets Obesity: Strong Association between the Global Overweight Population and COVID-19 Mortality

Jingzhou Wang et al.

JOURNAL OF NUTRITION (2021)

Add to Collection

Article Medicine, General & Internal

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Editorial Material Urology & Nephrology

COVID-19: implications for immunosuppression in kidney disease and transplantation

Andreas Kronbichler et al.

NATURE REVIEWS NEPHROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients

Jean-Francois Timsit et al.

INTENSIVE CARE MEDICINE (2019)

Add to Collection

Review Immunology

Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors

Raquel S. B. Stucchi et al.

TRANSPLANTATION (2018)

Add to Collection

Article Immunology

A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients

Yoichiro Natori et al.

CLINICAL INFECTIOUS DISEASES (2018)

Add to Collection

Review Surgery

Infection in Organ Transplantation

J. A. Fishman

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

Add to Collection

Article Medicine, General & Internal

PROSPERO's progress and activities 2012/13

Alison Booth

SYSTEMATIC REVIEWS (2013)

Add to Collection

Article Health Care Sciences & Services

GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Add to Collection

Review Health Care Sciences & Services

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)

Add to Collection

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.